Developer of rapid, non-invasive, and cost-effective diagnostic tests for respiratory infections.
PathoCare has raised $150.2M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in December 2024.
PathoCare's investors include Hamershlag Private.
PathoCare is headquartered in Houston, United States.
Developer of rapid, non-invasive, and cost-effective diagnostic tests for respiratory infections.
PathoCare is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"PathoCare — Funding & Investors." VCBacked, December 31, 2024, https://www.vcbacked.co/company/pathocare. Accessed August 14, 2026.
VCBacked. (2024). PathoCare — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/pathocare
{{cite web |title=PathoCare — Funding & Investors |url=https://www.vcbacked.co/company/pathocare |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated